A.C.O.M. - Advanced

Company snapshot

A.C.O.M. - Advanced is a pharma organization headquartered in EU. Primary therapeutic focus areas include Cancer on the prostatic bed, Prostate cancer at risk of developing metastatic lesions. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (2).

• 2 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 US patent(s) indexed to this assignee profile.
• 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for A.C.O.M. - Advanced. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for A.C.O.M. - Advanced.

1. Jun 8, 2026 Clinical update

   P.64Cu.003.01 — Phase 3

2. Jun 8, 2026 Clinical update

   64Cu(II)Cl2 solution for injection — Phase 3

3. Dec 27, 2007 Patent grant

   SYNTHÈSE CHIMIQUE DE LA CU-64ASP (CUIVRE-64ASPARAGINASE ; [64CU]ASPARARAGINASE) POUR PET SCAN ET RADIOTHÉRAPIE

View all clinical trial activity →

• What is A.C.O.M. - Advanced?

  A.C.O.M. - Advanced is a pharma organization headquartered in EU. Primary therapeutic focus areas include Cancer on the prostatic bed, Prostate cancer at risk of developing metastatic lesions. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) t

• Is A.C.O.M. - Advanced publicly traded?

  A.C.O.M. - Advanced appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does A.C.O.M. - Advanced develop or market?

  We link 4 drug profile(s) where A.C.O.M. - Advanced is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/a-c-o-m-advanced-center-oncology#company-drugs.

• What are the latest developments for A.C.O.M. - Advanced?

  In the last 12 months our linked public records show 2 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does A.C.O.M. - Advanced focus on?

  A.C.O.M. - Advanced focuses on Cancer on the prostatic bed, Prostate cancer at risk of developing metastatic lesions based on our analysis of their pipeline programs and drug development activities.